Address	6-8 Wallace Avenue Toorak Victoria (VIC) 3142 Australia
Employees	-
Website	http://www.antisense.com.au
Updated	07/08/2019
Antisense Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. It operates through the ATL1102, and ATL1103 segments. The ATL1102 segment represents the second generation antisense inhibitor of CD49d, the alpha subunit of very late antigen-four.